Yang J T, Rayburn H, Hynes R O
Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge 02139, USA.
Development. 1995 Feb;121(2):549-60. doi: 10.1242/dev.121.2.549.
alpha 4 integrins are cell surface receptors that mediate cell-extracellular matrix (ECM) and cell-cell adhesions by interacting with fibronectin (FN) and vascular cell adhesion molecule 1 (VCAM-1), respectively. We have generated a null mutation in the gene for the alpha 4 integrin subunit. Homozygous null embryos express no alpha 4 integrins and show two unexpected defects, both of which lead to embryonic lethality. The first defect is failure of fusion of the allantois with the chorion during placentation. The second is in the development of the epicardium and coronary vessels leading to cardiac hemorrhage. Both processes clearly involve alpha 4 integrin interactions that were previously unsuspected. alpha 4 integrin and VCAM-1 are expressed at the sites of these interactions. These results raise the possibility of abortifacients targeting alpha 4 integrins, and raise serious questions about potential side effects of drugs currently being designed to block alpha 4 integrin functions in inflammation.
α4整合素是细胞表面受体,分别通过与纤连蛋白(FN)和血管细胞黏附分子1(VCAM-1)相互作用来介导细胞与细胞外基质(ECM)以及细胞与细胞之间的黏附。我们在α4整合素亚基基因中产生了一个无效突变。纯合无效胚胎不表达α4整合素,并表现出两个意外的缺陷,这两个缺陷均导致胚胎致死。第一个缺陷是在胎盘形成过程中尿囊与绒毛膜融合失败。第二个缺陷是心外膜和冠状血管发育异常,导致心脏出血。这两个过程显然都涉及以前未被怀疑的α4整合素相互作用。α4整合素和VCAM-1在这些相互作用的部位表达。这些结果增加了以α4整合素为靶点的堕胎药的可能性,并对目前设计用于阻断α4整合素在炎症中功能的药物的潜在副作用提出了严重质疑。